yahoo_financeOriginal article
Pfizer’s Eczema Drug Hit a 61% Response Rate the Day Florida Sued. Here’s What It Means for the Stock
Data ReadoutpositivePositive
AI Analysis
Summary
Pfizer's eczema drug demonstrated a 61% response rate in clinical trial data. The positive results were announced on the same day Florida filed a lawsuit against the company.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
61% response rate
Importance:6/10
Sentiment:
0.60
eczemaclinical_trialdrug_developmentresponse_rate
Related Companies
Read the original article
Published by yahoo_finance on October 2, 2026 3:37 PM